Bupropion as a modulator of drug activity | Patent Number 10966942

US 10966942 B2
Application Number17025849
Publication NumberUS 20210000768 A1
Pendency6 months, 20 days
Filled DateSep 18, 2020
Priority DateJan 7, 2019
Publication DateJan 7, 2021
Expiration DateJan 6, 2039
Inventor/ApplicantsHerriot Tabuteau
ExaminesVALENROD, YEVGENY
Art Unit1628
Technology Center1600
Assignments
Antecip Bioventures Ii Llc Axsome
Current
Antecip Bioventures Ii Llc AxsomeAxsome Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.